John Strickler

机构：Duke University, Duke Medical Center, Durham VA Medical Center, Duke University Hospital

发表论文 16 篇 · 总被引 22 次 · h-index 3

代表论文

• Tucatinib plus trastuzumab for chemotherapy-refractory, HER2 + , RAS wild-type metastatic colorectal cancer (MOUNTAINEER): final analysis (2026 · Nature Communications · 被引 8)
• Zolbetuximab + pembrolizumab and chemotherapy as first-line treatment for patients with CLDN18.2-positive, HER2-negative, PD-L1-positive locally advanced unresectable or metastatic G/GEJ adenocarcinoma: Phase 3, double-blind, randomized trial (LUCERNA). (2026 · Journal of Clinical Oncology · 被引 7)
• BioSYNTHESIS: Integrating Multiple Databases into a Virtual Database. (1989 · PubMed Central · 被引 4)
• Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met–Targeting Antibody–Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer (2026 · Clinical Cancer Research · 被引 1)
• Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program (2026 · Cancer Cell · 被引 1)
• Prevalence and Clinical Characteristics of Germline Epidermal Growth Factor Receptor Mutations in the Southeastern United States (2026 · JCO Precision Oncology · 被引 1)